Lew Trowbridge is the Chairman and CEO of Canyon Road Advisors, LLC (CRA), a Santa Fe based consulting firm focused on helping companies use innovation to drive competitive advantage in the development of corporate strategy, with a primary focus in the healthcare/health insurance and financial services industries.
Lew retired as the President and COO of Blue Cross Blue Shield of Nebraska (BCBSNE) in 2016. Prior to being named president, he served as the Executive Vice President, Chief Financial Officer and Treasurer of the company. Under his leadership, BCBSNE developed one of the most extensive and financially successful private equity portfolios within the Blue Cross Blue Shield system.
Lew earned BBA and MBA degrees from the University of Cincinnati. In addition to his Advisory Board role with Echo Health Ventures, he currently serves on several health and innovation related corporate boards, including Think Nebraska, LLC, a first of its kind, integrated care delivery enterprise with 46,000 patients and 24 independent primary care physicians who share ownership in the clinic with private investors; Health Velocity Capital, a newly formed health focused private equity fund based in San Francisco and Nashville; Regional Health, a five hospital, 24 clinic care delivery system serving western South Dakota and eastern Wyoming; and Genesys Innovations, LLC, an Omaha based company focusing on driving innovation and disruption for positive change in the health insurance payer space. He is also a board member and audit committee chair of a $900 million regional bank in Omaha, a trustee of the W. David Scott Foundation and a strategic consultant to several health related organizations, including the San Francisco based Health Evolution Summit.
Lew was the co-founder of the Blue Investment Collaborative, a coalition of 10 like-minded Blue plans who meet regularly to discuss collaborative private equity investment opportunities. He is also the past chairman of International Plan Solutions, LLP, a joint venture formed by 14 Blue plans to focus on international health related investments.